The original success of Viagra undeniably transformed the drug landscape, but placing funds in companies heavily reliant on off-patent versions presents a complex picture. Although early returns were substantial, the cessation of patents and the emergence of discounted alternatives have weakened the customer base. Therefore, a thorough analysis of